Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05444855 · ClinicalTrials.gov registry record · NA
Increasing Teen Access to Sexual and Mental Health Care
A NA study of Health Care Utilization, sponsored by Children's Mercy Hospital Kansas City.
- Completed
- Registry status
- NA
- Development phase
- 51
- Enrollment target
- 1
- Study location
NCT05444855: Completed NA study of Health Care Utilization, sponsored by Children's Mercy Hospital Kansas City.
NCT05444855 is a NA study of Health Care Utilization that has completed, run by Children's Mercy Hospital Kansas City. The registered enrollment target is 51 participants, below the 919-participant average among 25 other Health Care Utilization trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05444855, a NA study of Health Care Utilization, has completed, sponsored by Children's Mercy Hospital Kansas City.
- COMPLETED
- Registry status
- NA
- Development phase
- 51 participants
- Enrollment target
- 1
- Study location
Study Summary
Investigators will form community partnership with community sites that will disseminate curated educational information on Sexual and Reproductive Health/Mental Health (SRH/MH). Investigators will attend a series of outreach events hosted by community partners community and community leaders that provide/demonstrate telemedicine and the Children's Mercy Mobile Unit which is equipped to provide direct patient care. Investigators will engage up to 40 teen peer leaders to encourage healthcare-seeking behaviors and mobilize their social networks to attend outreach events. At all events, the mobile unit will be available for teens to (a) demonstrate the mobile; (b) learn about Sexual and Reproductive Health/Mental Health (SRH/MH) and local care resources; (d) acquire free over-the-counter emergency contraception, birth control, condoms, and pregnancy tests.
Primary Outcome
Measurement of any use of healthcare utilization through trial. Healthcare utilization measured through surveys from participants at baseline, 2 months, 4 months, and 6 months.
Conditions Studied
Interventions
- OTHER Peer Leader Model
Study Locations (1)
Missouri
- Children's Mercy Hospital - Kansas City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2022-06-08 |
| Est. Completion | 2023-05-01 |
| Phase | NA |
What the finished NCT05444855 record still lists
NCT05444855 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 51 participants, a relatively small participant target, below the 919-participant average among 25 other Health Care Utilization trials with a reported enrollment target (94% lower).
The record links to 1 condition, with Health Care Utilization appearing as the primary indexed condition, and to 1 intervention - of which Peer Leader Model is the first listed.
NCT05444855 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT05444855 about?
NCT05444855 is a clinical study titled "Increasing Teen Access to Sexual and Mental Health Care". Investigators will form community partnership with community sites that will disseminate curated educational information on Sexual and Reproductive Health/Mental Health (SRH/MH). Investigators will attend a series of outreach events hosted by community partners community and community leaders that p...
What is the current status of trial NCT05444855?
This trial is currently completed. It is a NA study. The enrollment target is 51 participants. The study started on 2022-06-08. Estimated completion is 2023-05-01.
What conditions does trial NCT05444855 study?
This clinical trial studies the following conditions: Health Care Utilization.
What interventions are being tested in trial NCT05444855?
The interventions under investigation include: Peer Leader Model (OTHER).
Who is sponsoring clinical trial NCT05444855?
This trial is sponsored by Children's Mercy Hospital Kansas City, which has 184 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05444855 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Health Care Utilization
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05444855's enrollment target sits among peer trials
51 23rd of 25 higher than 3 of 25 other Health Care Utilization trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Health Care Utilization trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Comprehensive Connected Cancer Care (C4): Intervention Evaluation
RECRUITING · NA
-
UCSD RELINK: Connecting Adults To Supportive Services
RECRUITING · NA
-
ACP Video Intervention for Patients With Life-Limiting Illness
RECRUITING · NA
-
Evaluation of a Health System Integrated Model for Postpartum Education and Support in Rural Populations
RECRUITING · NA
-
Fresh RX: NHS 2020
RECRUITING · NA
-
Universal Basic Income and Structural Racism in the US South: HIV Care
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02701153 · 51 participants · NA
Phase II Study of 5-Day Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcomas: Expansion Cohort
- NCT03663790 · 51 participants · NA
Effects of Gait Retraining on Lower Extremity Biomechanics
- NCT03874052 · 51 participants · Phase 1
Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
- NCT04704661 · 51 participants · Phase 1
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI